Description
TIRZ – 60mg is a research-grade Tirzepatide peptide designed exclusively for laboratory use in pre-clinical settings. Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It has been shown in scientific studies to influence insulin secretion, reduce appetite, and support glucose metabolism.
Researchers are particularly interested in Tirzepatide for its potential applications in managing metabolic disorders, including type 2 diabetes and obesity. By activating both GIP and GLP-1 receptors, Tirzepatide may promote synergistic effects on insulin sensitivity, glycemic control, and weight reduction in experimental models.
For Research Use Only:
This product is not intended for human or veterinary use. It is strictly for laboratory research purposes and must be handled only by qualified professionals in a controlled environment.
